510(k) Report

510(k) · Cleared

Recalled · Class II · 2025

Pristina Serena

K173576510(k) TraditionalCleared May 14, 2018175-day reviewClass II21 CFR 892.1715Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

GE Healthcare · MUE Full Field Digital, System, X-Ray, Mammographic

Cleared on May 14, 2018 as substantially equivalent to K040125 (Ge Medical Systems, Inc., 2004) after a 175-day review. Its family tree reaches back 2 generations to 1995. 2 later devices descend from it. It has been recalled 3 times.

Decided
May 14, 2018
Review
175 days
Class
Class II
Product code
MUE
Recalls
3
Predicates
1

Its longest line of descent runs back 2 generations to K941191 (1995). 2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2019: 1 descendant cleared2020: 1 descendant clearedReference device: K162268 · Senographe Pristina · GE Healthcare · 2016 · recalledK941191 · Real Time Stereotix · GE Medical Systems · 1995 · recalledK040125 · Senographic Stereo · Ge Medical Systems, Inc. · 20041995200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants K040125 · Senographic Stereo · Ge Medical Systems, Inc. · 2004K941191 · Real Time Stereotix · GE Medical Systems · 1995 · recalled0
  1. Root · 2 generations backK941191 Real Time StereotixGE Medical Systems · 1995 · Recalled
  2. 1 generation backK040125 Senographic StereoGe Medical Systems, Inc. · 2004
  3. This deviceK173576 Pristina SerenaGE Healthcare · 2018
  4. Descendant · cites it directly · 0 of its ownK193334 Pristina Serena BrightGE Healthcare · 2020 · Recalled
  5. Descendant · cites it directly · 0 of its ownK182951 Pristina Serena 3DGE Healthcare · 2019 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K193334Pristina Serena BrightGE Healthcare · 2020 · cites it directly0descendants
  • K182951Pristina Serena 3DGE Healthcare · 2019 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K941191Real Time StereotixGE Medical Systems19952
−1K040125Senographic StereoGe Medical Systems, Inc.2004—
0 (this device)K173576Pristina SerenaGE Healthcare2018—
+1K193334Pristina Serena BrightGE Healthcare20201
+1K182951Pristina Serena 3DGE Healthcare20192

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
202010
FIG. 1 — Lineage of K173576, 1995–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MUE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MUE device

  1. #1 K253678 MAMMOMAT B.brilliant (11372950)score 13.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040125Senographic Stereo
Summary page 4
…ssification Names: 21 CFR 892.1715, Full-field digital mammography system, Class II Product Code: MUE Predicate Device(s): Senographe Stereo (K040125) Reference Predicate(s) Senographe Pristina (K162268) Device Description: Pr…
Ge Medical Systems, Inc.2004—
†K162268Senographe PristinaGE Healthcare20163

Also cleared against K040125: 2 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K193334Pristina Serena BrightGE Healthcare20200
K182951Pristina Serena 3DGE Healthcare20190

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 24, 2025Class IIZ-0875-2026Radiation Control for Health and Safety ActSome Senographe Pristina systems either have a missing or an incorrect X-Ray Warning label, which is a nonconformance to FDA Regulation 21 CFR 1020.30(j).
Dec 26, 2023Class IIZ-0862-2024Radiation Control for Health and Safety ActX-ray exposure termination audible signal on Senographe Pristina with Efficiency Suite 2 intermittently not emitted per 21CFR 1020.31(j) requirements.
May 16, 2019Class IIZ-2132-2019Equipment maintenancePotential slippage of the biopsy positioner when the gantry is rotated during a biopsy procedure.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 14.1 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K193334 (GE Healthcare, 2020) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K040125.

How does its category compare?

All MUE devices

MUE Full Field Digital, System, X-Ray, Mammographic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · MUE

3in 2025

2007: 62008: 52009: 82010: 102011: 102012: 42013: 72014: 12015: 12016: 12017: 82018: 22019: 22020: 42021: 42022: 32023: 12024: 12025: 32026 (partial year): 4
2007high 10 (2010) · low 1 (2014)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MUE

255in 2025

2011: 192 days median2012: 123 days median2013: 207 days median2017: 95 days median2020: 188 days median2021: 164 days median2022: 404 days median2025: 255 days median2026 (partial year): 185 days median
2007high 404 (2022) · low 95 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MUE

4in 2025

2008: 12009: 12010: 22011: 52014: 22017: 62018: 12019: 12023: 12025: 42026 (partial year): 1
2007high 6 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MUE

40in 2025

2008: 42009: 32010: 22011: 102012: 62013: 112014: 72015: 62016: 192017: 1152018: 1452019: 802020: 492021: 252022: 362023: 292024: 332025: 40
2007high 145 (2018) · low 0 (2007)2025

MAUDE reports naming product code MUE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076—00
20085—14
20098—13
201010—22
201110192510
2012412306
20137207011
20141—27
20151—06
20161—019
20178956115
20182—1145
20192—180
20204188049
20214164025
20223404036
20231—129
20241—033
20253255440
202641851—

What is it indicated for?

The Pristina Serena option provides the three-dimensional location of target lesions, using information obtained from stereotactic pairs of two-dimensional X-ray images. This information provides guidance for a variety of minimally invasive or interventional procedures in the breast such as: vacuum assisted biopsy, core biopsy, pre-surgical localization (e.g. hookwire), and fine needle aspirations (FNA).

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K173576: Pristina Serena.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K173576

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026